Sfoglia per Rivista
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.
1992-01-01 ZACCARIA A ;MARTINELLI G ;BUZZI M ;ZUFFA E ;ZAMAGNI MD ;TESTONI N ;RUSSO D ;GUERRASIO A ;SAGLIO G ;TURA S
MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.
1990-01-01 Tarella C; Gallo E; Ferrero D; Badoni R; Carlesso N; Caracciolo D; Pileri A.
MAKING THE RIGHT CHOICE: THE ROLE OF FITNESS STATUS IN THE MANAGEMENT OF FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL FITNESS STUDY)
2015-01-01 Scarfo, L; Quaresmini, G; Mauro, Fr; Orlandi, E; Reda, G; Laurenti, L; Coscia, M; Ambrosetti, A; Murru, R; Trentin, L; Guelill, A; Visco, C; Morabito, F; Frustaci, A; Ciolli, S; Rossini, F; Cuneo, A; Gozzetti, A; Scortechini, I; Pane, F; Zinzani, Pl; Ferrara, F; Mannina, D; Marasca, R; Pierri, I; Specchia, G; Chiarenza, A; Zallio, F; Molica, S; De Paoli, L; Torreggiani, A; Brugiatelli, M; Semenzato, G; Innocenti, I; Picardi, P; Pizzolo, G; Foa, R; Rambaldi, A; Ghia, P
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO)
2004-01-01 Barosi, G; Boccadoro, M; Cavo, M; Corradini, P; Marchetti, M; Massaia, M; Merlini, G; Tosi, P; Tura, S; Palumbo, A
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
2006-01-01 BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation
2005-01-01 BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S
Marriage and parenthood among subjects cured of childhood cancer: a report from the Italian AIEOP Off-Therapy Registry
2011-01-01 Pivetta E; Maule MM; Pisani P; Zugna D; Haupt R; Jankovic M; Arico' M; Casale F; Clerico A; Cordero di Montezemolo L; Kiren V; Locatelli F; Palumbo G; Pession A; Pillon M; Santoro N; Terenziani M; Valsecchi MG; Dama E; Magnani C; Merletti F; Pastore G.
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway.
2014-01-01 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
2010-01-01 Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P; Italian Multiple Myeloma Network GIMEMA.
MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSO MELPHALAN (200 MG/M2) E TRAPIANTO AUTOLOGO (MEL200) IN PAZIENTI CON NUOVA DIAGNOSI DI MIELOMA MULTIPLO (MM): UNO STUDIO DI FASE III.
2011-01-01 Cavallo F; Lupo B; Di Raimondo F; Ben Yehuda D; Corradini P; Patriarca F; Cavo M; Carella AM; Omedè P; Stanevsky S;Siniscalchi A; Cavalli M; Marcatti M; Petrò D; Crippa C; Levi A; Caravita Di Toritto T; Nagler A; Boccadoro M; Palumbo A
MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSUS HIGHDOSEMELPHALAN AND AUTOLOGOUS TRANSPLANTATION (MEL200)IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS: APHASE III STUDY
2011-01-01 A Palumbo; F Cavallo; B Lupo; A Nagler; V Redoglia; M Cavalli; A Carella; A Cafro; F Patriarca; A Siniscalchi; F Rossini; C Crippa; P Corradini; M Cavo; S Grammatico; A Stanevsky; D Ben Yehuda; F Di Raimondo; T Caravita Di Toritto; M Boccadoro
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells
2007-01-01 Rustichelli D; Mareschi K; Ferrero I; Manetta T; De Fazio R; Anselmino A; Morterra G; Gunetti M; Comunanza V; Carbone E; Fagioli F
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells
2008-01-01 Mareschi K; Rustichelli D; Ferrero I; Comunanza V; Fazio R; Saglio F; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL)
2008-01-01 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
Microsatellite analysis in childhood acute lymphoblastic leukemia
1998-01-01 Reato G; Basso G; Putti MC; Cignetti A; Guarini A; Foa R
Il Mieloma multiplo.
1991-01-01 Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A
MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM
2013-01-01 Ladetto M.; Bruggeman M; Monitillo L.
Minimal residual disease in acute myeloid leukemia detected by Wilms tumor gene 1 expression and multiparameter flow cytometry.
2014-01-01 4. FRAIRIA C., AYDIN S., RIERA L., ALIBERTI S., ALLIONE B, AUDISIO E., D'ARDIA S., DEMURTAS A., FRANCIA DI CELLE P., NICOLINO B., PECORARO C., STACCHINI A., MARMONT M., VITOLO U
Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?
2017-01-01 Simone, Ferrero; Martin, Dreyling
Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement
2015-01-01 Pigazzi, Martina*; Manara, Elena; Buldini, Barbara; Beqiri, Valzerda; Bisio, Valeria; Tregnago, Claudia; Rondelli, Roberto; Masetti, Riccardo; Caterina Putti, Maria; Fagioli, Franca; Rizzari, Carmelo; Pession, Andrea; Locatelli, Franco; Basso, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia. | 1992 | ZACCARIA A ;MARTINELLI G ;BUZZI M ;ZUFFA E ;ZAMAGNI MD ;TESTONI N ;RUSSO D ;GUERRASIO A ;SAGLIO G ;TURA S | |
| MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse. | 1990 | Tarella C; Gallo E; Ferrero D; Badoni R; Carlesso N; Caracciolo D; Pileri A. | |
| MAKING THE RIGHT CHOICE: THE ROLE OF FITNESS STATUS IN THE MANAGEMENT OF FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL FITNESS STUDY) | 2015 | Scarfo, L; Quaresmini, G; Mauro, Fr; Orlandi, E; Reda, G; Laurenti, L; Coscia, M; Ambrosetti, A; Murru, R; Trentin, L; Guelill, A; Visco, C; Morabito, F; Frustaci, A; Ciolli, S; Rossini, F; Cuneo, A; Gozzetti, A; Scortechini, I; Pane, F; Zinzani, Pl; Ferrara, F; Mannina, D; Marasca, R; Pierri, I; Specchia, G; Chiarenza, A; Zallio, F; Molica, S; De Paoli, L; Torreggiani, A; Brugiatelli, M; Semenzato, G; Innocenti, I; Picardi, P; Pizzolo, G; Foa, R; Rambaldi, A; Ghia, P | |
| Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO) | 2004 | Barosi, G; Boccadoro, M; Cavo, M; Corradini, P; Marchetti, M; Massaia, M; Merlini, G; Tosi, P; Tura, S; Palumbo, A | |
| Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation | 2006 | BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S | |
| Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation | 2005 | BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S | |
| Marriage and parenthood among subjects cured of childhood cancer: a report from the Italian AIEOP Off-Therapy Registry | 2011 | Pivetta E; Maule MM; Pisani P; Zugna D; Haupt R; Jankovic M; Arico' M; Casale F; Clerico A; Cordero di Montezemolo L; Kiren V; Locatelli F; Palumbo G; Pession A; Pillon M; Santoro N; Terenziani M; Valsecchi MG; Dama E; Magnani C; Merletti F; Pastore G. | |
| Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. | 2014 | P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia. | |
| Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial | 2010 | Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P; Italian Multiple Myeloma Network GIMEMA. | |
| MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSO MELPHALAN (200 MG/M2) E TRAPIANTO AUTOLOGO (MEL200) IN PAZIENTI CON NUOVA DIAGNOSI DI MIELOMA MULTIPLO (MM): UNO STUDIO DI FASE III. | 2011 | Cavallo F; Lupo B; Di Raimondo F; Ben Yehuda D; Corradini P; Patriarca F; Cavo M; Carella AM; Omedè P; Stanevsky S;Siniscalchi A; Cavalli M; Marcatti M; Petrò D; Crippa C; Levi A; Caravita Di Toritto T; Nagler A; Boccadoro M; Palumbo A | |
| MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSUS HIGHDOSEMELPHALAN AND AUTOLOGOUS TRANSPLANTATION (MEL200)IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS: APHASE III STUDY | 2011 | A Palumbo; F Cavallo; B Lupo; A Nagler; V Redoglia; M Cavalli; A Carella; A Cafro; F Patriarca; A Siniscalchi; F Rossini; C Crippa; P Corradini; M Cavo; S Grammatico; A Stanevsky; D Ben Yehuda; F Di Raimondo; T Caravita Di Toritto; M Boccadoro | |
| Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells | 2007 | Rustichelli D; Mareschi K; Ferrero I; Manetta T; De Fazio R; Anselmino A; Morterra G; Gunetti M; Comunanza V; Carbone E; Fagioli F | |
| Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells | 2008 | Mareschi K; Rustichelli D; Ferrero I; Comunanza V; Fazio R; Saglio F; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F | |
| The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) | 2008 | M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia | |
| Microsatellite analysis in childhood acute lymphoblastic leukemia | 1998 | Reato G; Basso G; Putti MC; Cignetti A; Guarini A; Foa R | |
| Il Mieloma multiplo. | 1991 | Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A | |
| MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM | 2013 | Ladetto M.; Bruggeman M; Monitillo L. | |
| Minimal residual disease in acute myeloid leukemia detected by Wilms tumor gene 1 expression and multiparameter flow cytometry. | 2014 | 4. FRAIRIA C., AYDIN S., RIERA L., ALIBERTI S., ALLIONE B, AUDISIO E., D'ARDIA S., DEMURTAS A., FRANCIA DI CELLE P., NICOLINO B., PECORARO C., STACCHINI A., MARMONT M., VITOLO U | |
| Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach? | 2017 | Simone, Ferrero; Martin, Dreyling | |
| Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement | 2015 | Pigazzi, Martina*; Manara, Elena; Buldini, Barbara; Beqiri, Valzerda; Bisio, Valeria; Tregnago, Claudia; Rondelli, Roberto; Masetti, Riccardo; Caterina Putti, Maria; Fagioli, Franca; Rizzari, Carmelo; Pession, Andrea; Locatelli, Franco; Basso, Giuseppe |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile